GeoVax Labs Inc (GOVX) 銘柄情報

GOVX...$2.00...Scaling in on the $1.95 Dip...🥳... https://finance.yahoo.com/news/geovax-advanced-mva-manufacturing-process-140000479.html

Bottom in low $2s as W pattern established ready for breakout soon. Could mean news 

$2.74?Cancer vaccine patent awarded and remember 500 million from other studies being awarded by government low floater 

Bullish?

GOVX....................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783

Anyone know if they working on H5N1?

go go

GOVX...................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783

GOVX $3.57 + 80% kept a few $1.70s. 

GOVX $2.80s + 50%🔥🔥🔥🔥📞🚀🚀🚀🚀

Rockets fired $2.70s + 40% sold most 

govx...............................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783

GOVX $1:96 + 1% earnings 11-12

Have plenty of $1.70s financial results Nov 12 afterhours 

Some climbing again 2.26

crawling out of its hole
keep on watch

GOVX 2.20s offshore hedgies hit some.. The government will also provide around $343M for a clinical research organization to conduct the clinical trial. Under the agreement, BARDA will award GeoVax up to $45M for the manufacturing of clinical materials and support for the Phase 2b study

GARBAGE, TRASH, WORTHLESS

$2.07 Offshore hedgies could hit here again but could be a month or two out still

Ok $1.90- $2s flipper

Confirm reversal on candle on 3rd day

Ok ok we see you ..but going to hold $3s this time or another fake out. Support been at $2.60s past few weeks. Looking better

Mpox has spread to at least 14 African countries, including Morocco, which has confirmed its first case in the current outbreak. (Source: BBC Africa)
The Democratic Republic of Congo (DRC) is the epicenter of the outbreak, with over 20,000 cases reported and more than 500 deaths. (Source: WHO)
Neighboring countries, such as Burundi, Kenya, Rwanda, and Uganda, have also reported cases. (Source: WHO)
Vaccination Efforts

The World Health Organization (WHO) recommends use of MVA-BN or LC16 vaccines, or the ACAM2000 vaccine when others are not available. (Source: WHO)
Only people at risk of exposure to mpox should be considered for vaccination, according to WHO. (Source: WHO)
Transmission and Prevention

Mpox is primarily spread through close person-to-person contact with someone who is infected, including through sex. (Source: Nature)
Cleaning and disinfecting surfaces or objects and washing hands after touching contaminated surfaces or objects can help prevent transmission. (Source: WHO)
Avoiding unprotected contact with wild animals, especially those that are sick or dead, and cooking food thoroughly can reduce the risk of getting mpox from animals. (Source: WHO)
Public Health Emergency

The WHO declared the mpox outbreak a Public Health Emergency of International Concern (PHEIC) on August 19, 2024, citing the rapid spread of a new, more transmissible strain of the virus. (Source: WHO)
Research and Development

Scientists are racing to answer questions about the outbreak, including whether vaccines will curb the spread and how the virus is transmitted. (Source: Nature)

Looking good bottom about in for hedgies

Watch for 2.52 - .2.92 too hold for flip. 2.08- 2.20 next zone underneath if doesn’t

Hedgies determine new downtrend. New entry as we see $2.80s for another flip

Ok hedgies confirming new upward trend perhaps give it a few hours still

Flip the $3.06 at 3.30s and wait for hedgies to determine direction

Tummies yummy $3.06 bought and then if happens to test next level down add again.
Hedgies want to take it as low as possible before the next big run into Covid vaccine season. Luv you Gary Gensler

Good sign 3.06 hedgies covering shorts now volume picking up 600,000. Almost time to add some more goodies

3.19 zone being tested if holds a few days start adding some again

price of $5.125 per share for expected gross proceeds of $5 million.

4:39 AM EDT, 08/29/2024 (MT Newswires) -- GeoVax Labs (GOVX) said late Wednesday it has agreed to sell 975,610 common shares in a registered direct offering to an institutional investor at a price of $5.125 per share for expected gross proceeds of $5 million.

The company will also issue warrants to purchase up to 975,610 common shares to the investor in a concurrent private placement, it said. The warrants will be exercisable at a price of $5 per share.

Net proceeds will be used for working capital and general corporate purposes, the company said.

The offering is expected to close around Friday, sub

Test 3.19- 3.55 zone wait to confirm before pulling trigger $2.52- 2.92 is the other zone. The hedgies that have most of the shares will determine that as they move this one as they please

Covid flue season blooming still holding a few here but inclined to add some more ..

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world’s most threatening infectious diseases and therapies for solid tumor cancers. The company’s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com.

Going under 2.00 then time to buy.

GOVX under $5

Warrents jumped up 100%

The Fauch knows how to party!

Maybe the evil bastard will drop dead .

Buy 6.30s sell $7.30s was todays lesson dip time coming again.. Dr. Fauci Somehow Contracts Ultra-Rare West Nile Virus On Heels Of COVID-19 Infection

Good, keep giving that evil idiot all my vaccines and boosters.
He should double up

Catch the dips play next.. Dr. Fauci has COVID again for the third time and has been vaccinated and boosted six times

GOVX...............................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783

sale of 1,700,000 shares of the Company’s common stock (or common stock equivalents) at a price of $5.00 per share in a registered direct offering priced above-the-market under Nasdaq rules.
In addition, in a concurrent private placement, the Company will issue to the investor warrants to purchase up to 1,700,000 shares of common stock. The warrants have an exercise price of $5.00 per share, will be exercisable immediately following the date of issuance and will have a term of five years from the date of issuance.

I wish ..

15 to 20 let's goooo

Next stop $15 then $20…By Amanda Alvarado
Published: Aug. 21, 2024 at 8:02 AM EDT
(Gray News) - COVID-19 cases are rising and KP.3.1.1 is the predominant variant in the United States, according to the Centers for Disease Control and Prevention.

The variant accounted for between 31% and 43% of the cases in the two-week period ending on Aug. 17.

KP.3.1.1 is currently the only major variant increasing in proportion nationally, according to the CDC.

Emergency room visits diagnosed as COVID-19 started increasing in May in the West and are now the highest in the South and Southeast. The wastewater viral activity level for COVID-19 has been rising since mid-May and is currently very high across most parts of the country, according to the CDC.

- Kamala Harris issues vaccine mandate for campaign workers..Good news for vaccine makers pump em up.

Still have $1.80 shares left from a couple weeks back holding for the Gold longer term rest been cashed out

GOVX....................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783